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An open reading frame (ORF) situated between the UL20 and UL21 genes encodes a protein designated as UL20.5. The
UL20.5 ORF lies 59 and in the same orientation as the UL20 ORF. The expression of the UL20.5 ORF was verified by RNase
protection assays and by in-frame insertion of an amino acid sequence encoding an epitope of an available monoclonal
antibody. The tagged UL20.5 protein colocalized in small dense nuclear structures with products of the a22/US1.5, UL3, and
UL4 genes. Expression of the UL20.5 gene was blocked in cells infected and maintained in the presence of phosphonoacetate,
indicating that it belongs to the late, or g2, kinetic class. UL20.5 is not essential for viral replication inasmuch as a recombinant
virus made by insertion of the thymidine kinase gene into the UL20.5 ORF replicates in all cell lines tested [J. D. Baines, P. L.
Ward, G. Campadelli-Fiume, and B. Roizman (1991) J. Virol. 65, 6414–6424]. The genomic location of the recently discovered
genes illustrates the compact nature of the viral genome. © 2000 Academic Press
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The herpes simplex virus 1 (HSV-1) genome is a linear
double-stranded DNA molecule of approximately 152
kbp. It consists of two unique sequences: unique long
(UL) flanked by ab and its inversion, b9a9, and unique
short (US) flanked by a9c9 and its inversion, ca (Sheldric
and Berthelot, 1975; Wadsworth et al., 1975). McGeoch et
al. (1988) reported on the basis of the sequence of HSV-1
DNA and available transcript maps that UL contains at
east 56 open reading frames (ORFs), that US contains 12,
and that the repeats flanking UL and US contain two
copies of a total of three genes. Since the publication of
that report, several additional genes have been reported:
these include UL8.5, UL9.5, UL26.5, UL27.5, UL43.5, UL49.5,
S1.5, and US8.5 in unique domains and g134.5 and ORFs
and P in the b sequence flanking UL (Baradaran et al.,
1994; Barker and Roizman, 1992; Carter and Roizman,
1996; Chang and Roizman, 1998; Chou and Roizman,
1990; Georgopoulou et al., 1993; Lagunoff and Roizman,
1994; Liu and Roizman, 1991; Randall et al., 1997; Ward et
al., 1996). We report here yet another ORF that is ex-
pressed in the course of productive infection by HSV-1.
This ORF, designated UL20.5, is situated between UL20
and UL21 ORFs and belongs to the late, or g2, group
nasmuch as its expression is dependent on ongoing
iral DNA synthesis. UL20.5 protein accumulates in small
dense nuclear structures together with at least three
other viral gene products.1 To whom reprint requests should be addressed. Fax: (312) 702-1631.
27RESULTS
An ORF situated between UL20 and UL21 (UL20.5) is
xpressed
Two series of experiments were performed to deter-
ine whether the UL20.3, UL20.5, or UL20.8 ORFs were
expressed. In the first, we used RNase protection assays
to determine whether infected cells contained RNA se-
quences homologous to the domain located between the
UL20 and UL21 genes (includes UL20.5 and UL20.8 ORFs;
ig. 1). The assays were performed as described in
aterials and Methods. The experiment shown in Fig. 2A
as designed to assay for the presence of transcripts
omologous to the UL20.5 ORF. As shown in this figure,
NA extracted from the infected HEp-2 or Vero cells
rotected the 440 b sequences homologous to the
L20.5 ORF, whereas RNA extracted from mock-infected
cells did not protect the HSV-1 sequences in the labeled
probe. Figure 2B shows that RNA transcripts homolo-
gous to the UL20.8 ORF also protect the 440 b labeled
HSV-1 sequences in the probe from degradation,
whereas the RNA extracted from mock-infected cells did
not. In this instance, however, we cannot differentiate
between the possibility that the infected cell RNA is
derived from the transcription of UL21 rather than the
UL20.8 ORF. We also noted the presence of a protected
species of approximately 180 b (Fig. 2B), which may
reflect the presence of a secondary transcriptional start
site for the UL21 gene (see Fig. 1 for approximate loca-
tions of potential TATA sequences upstream of the UL21
gene).
The second series of experiments was designed to
0042-6822/00 $35.00
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276 WARD ET AL.determine whether UL20.3, UL20.5, or UL20.8 expresses
protein products. To determine whether the ORFs ex-
pressed a protein product, we constructed recombinant
viruses in which epitope tags were inserted in-frame
with each ORF (Fig. 3). To detect the UL20.5 protein
product, we constructed a recombinant virus in which
cytomegalovirus (CMV) tag 1 containing a KpnI restric-
tion site was inserted into the BstEII site of pRB4651 (Fig.
4, line 4) in-frame with the UL20.5 gene. This plasmid was
cotransfected into rabbit skin cells along with viral DNA
purified from R7214-infected cells. The recombinant virus
R7214 prepared for another study conveniently contained
an a27-tk gene between UL20 and UL21 (Baines et al.,
991). The resulting recombinant virus designated as
7420 was selected on 143TK2 cells and purified as
escribed under Materials and Methods. Immunoblot
nalysis of proteins produced in cells infected with
7420 with the CMV epitope-specific antibody revealed
hat the amounts of protein produced by the UL20.5 gene
were low (data not shown). We sought to increase the
FIG. 1. Sequence arrangements of putative ORFs in the region of
L20 and UL21 and the sequences used to generate riboprobes for
etection of transcripts in this region. The top line represents the HSV-1
iral genome. The genome consists of two covalently linked unique
egions designated as unique long (UL) and unique short (US) which are
each flanked by inverted repeat sequences (open boxes). The ex-
panded area of the UL region includes nucleotides from approximately
1,700 to 43,000. Five ORFs in addition to the known genes UL20 and
UL21 are indicated. Four of these ORFs and the UL21 gene are oriented
n the three forward reading frames, whereas the fifth and the UL20
gene are oriented in the reverse reading frames. Riboprobes were
generated by transcription of DNA sequences encompassing nucleo-
tides 41,597–42,037 using either the T7 or SP6 promoters as described
in Materials and Methods. The approximate locations of potential TATA
sequences for transcription of the UL21 gene are also indicated. B,
BamHI; Bg, BglII; Bs, BsteII; Ps, PstI.sensitivity of our detection system by insertion of a sec-
ond CMV tag in the UL20.5 gene. An oligonucleotide(CMV tag 2) encoding the CMV epitope was synthesized
in which the wobble base of as many codons as possible
was changed without changing the amino acid sequence
to minimize the chance for recombination with the CMV
epitope sequence already present in the gene. In addi-
tion, an EcoRV restriction enzyme site was included in
the epitope to differentiate it from the CMV tag 1. To
construct this double-tagged recombinant virus,
pRB4795 was digested with DraIII, and the CMV epitope
with DraIII cohesive ends was inserted in-frame with
UL20.5. The resulting plasmid, designated pRB4858 (Fig.
4, line 6), was cotransfected into rabbit skin cells along
with R7214 viral DNA and selected as described above.
Southern blot analysis of the double-tagged recombinant
virus (designated R7422) is shown in Fig. 5. HSV-1(F) and
R7422 viral DNAs were digested with KpnI (to indicate
presence of CMV tag 1; Fig. 5, lanes 1 and 2) or EcoRV
(indicative of CMV tag 2; Fig. 5, lanes 3 and 4) and
probed with nick-translated pRB4324 (Fig. 4, line 3).
pRB4324 hybridized to the HSV-1(F) 9.4-kbp KpnI H frag-
ment (Fig. 5, lane 1). The presence of CMV tag 1 results
in two bands of 7.5 and 1.9 kbp (bands 1 and 2; Fig. 5,
lane 2). pRB4324 hybridized to the HSV-1(F) EcoRV B
fragment of approximately 16.7 kbp (Fig. 5, lane 3). The
presence of CMV epitope 2 in R7422 resulted in two
unique bands of approximately 14 and 2.3 kbp (bands 3
and 4; Fig. 5, lane 4). Digestion of both CMV-tagged
viruses with BamHI and hybridization with nick-trans-
lated pRB4324 showed that both viruses were pure and
did not contain demonstrable parental (R7214) virus (Fig.
5, lanes 5–7). The insertion of the a27-tk gene within
amHI T increases the size of this fragment to approxi-
ately 4.6 kbp (Baines et al., 1991). In R7422, the 2.8-kbp
SV-1(F) BamHI T fragment was slightly increased in
ize due to the presence of the two CMV tags (Fig. 5,
ane 7).
To construct the tagged UL20.8 recombinant virus,
RB4796 was cotransfected into rabbit skin cells along
ith viral DNA purified from R7214-infected cells. The
esulting recombinant virus designated as R7427 was
elected on 143TK2 cells and purified as described un-
der Materials and Methods. Southern blot analysis of the
tagged recombinant virus R7427 is shown in Fig. 6. R7427
and a parental-type genotype viral DNA were digested
with KpnI to indicate the presence of the CMV tags and
probed with nick-translated pRB4324 (Fig. 6, lanes, 1 and
2). In the parental genotype virus, the KpnI H fragment is
an 11.3-kbp fragment (Fig. 6, lane 1). The presence of the
CMV tag in R7427 resulted in two unique bands of ap-
proximately 7.7 and 1.7 kbp (Fig. 6, lane 2).
To assay for UL20.5 protein expression, HEp-2 cells
were either mock-infected or infected with 10 PFU/cell of
HSV-1(F) wild-type virus or with the recombinant viruses
R7422 or R7427, which carry CMV epitope tags in UL20.5
and UL20.8 ORFs, respectively. In addition, the cells were
infected in the either presence or absence of 300 mg of
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277THE UL20.5 GENE OF HSV-1phosphonoacetate/ml of medium. At this concentration
of the drug, viral DNA synthesis is completely abolished,
and the expression of g2 genes, whose synthesis is
tringently dependent on viral DNA replication, is
locked. Cells were harvested 24 h after infection, solu-
ilized, and subjected to electrophoresis in denaturing
els. The proteins were transferred to a nitrocellulose
heet and reacted with the monoclonal antibody specific
or the CMV epitope. The results (Fig. 7) indicate that the
L20.5 ORF encodes a protein with an apparent Mr of
8,000, including the two 20-amino-acid CMV tags. Ex-
luding these tags, we would expect the UL20.5 protein
o have an apparent Mr of approximately 24,000. The
CMV monoclonal antibody did not react with electro-
phoretically separated proteins from either mock- or
HSV-1(F)-infected cells (Fig. 7). Immunoblot analysis of
proteins produced in cells infected with R7427, however,
failed to reveal the presence of a CMV-tagged protein
(Fig. 7) even when we increased the sensitivity of the
assay by using enhanced chemiluminescent substrate
for the immunoblot (data not shown). The UL20.5 gene is
FIG. 2. Autoradiographic images of 32P-labeled RNA fragments gene
A 440 b fragment of HSV sequences corresponding to the UL20.5 ORF a
rom mock-infected cells. (B) 440 and 172 b fragments of HSV sequenc
RNA extracted from infected HEp-2 and Vero cells and absent from mo
NA size markers are indicated.rated by RNase protection assay as described in Materials and Methods. (A)
re protected by RNA extracted from infected HEp-2 and Vero cells and absent
es corresponding to the region antisense to the UL20.5 ORF are protected byexpressed as a g2 or true late gene inasmuch as its
expression is blocked in the presence of phosphonoac-
t
aFIG. 3. Sequence arrangements of the three ORFs in the UL20–UL21
egion in which epitope tags were inserted. The known genes UL20 and
UL21 are indicated in black. The CMV epitope tag (black ovals) was
nserted into the HincII site within the 20.3 ORF, into the DraII site within
he 20.8 ORF, and into both the BsteII and DraIII sites of the 20.5 ORF
s described under Materials and Methods.
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278 WARD ET AL.etate (Fig. 7). We did not detect any protein expressed
from the CMV-tagged UL20.3 ORF (data not shown).
he UL20.5 protein localizes in the nucleus of
nfected cells
Two series of experiments were performed to deter-
ine the localization of UL20.5 protein in infected cells. In
the first experiment, HEp-2 cells were infected with
R7422 and harvested at 20 h after infection, and nuclear
and cytoplasmic fractions were prepared as described
under Materials and Methods. Figure 8 shows that the
UL20.5 protein partitioned with the nuclear fraction.
In the second experiment, we performed immunofluores-
cence experiments to analyze the distribution of UL20.5 in
the infected cell nucleus. Using monoclonal antibody to the
CMV tag present in UL20.5, we observed that the protein
was distributed in discrete patches in the internal portions
of the nucleus and appeared to be excluded from the
nuclear membrane (data not shown). The infected cell nu-
cleus contains several compartments in which various viral
functions are thought to occur (de Bruyn Kops and Knipe,
FIG. 4. Sequence arrangements of plasmids used for the insertion of
MV epitope tags into the UL20.5 ORF. Lines 1 and 2, locations within
he genome of HSV-1(F) of the BamHI B9, F9, and T fragments and of the
L20, UL20.5, and UL21 genes; line 3, sequence arrangement of plas-
id pRB4324, a subclone of the region containing the UL20 and UL20.5
enes; line 4, expanded view of the arrangement of pRB4651, which
ontains the BglII–SacI fragment of pRB4324 encompassing the entire
L20.5 ORF. CMV tag 1 was inserted into the BstEII site of UL20.5 to
generate pRB4795; line 5, insertion of CMV tag 2 into the DraIII site of
UL20.5 in pRB4795 to generate pRB4858; and line 6, representation of
RB4858, which contains both CMV tags. Restriction sites: B, BamHI;
s, BstEII; D, DraIII; Ps, PstI; S, SacI. Filled ovals (1ines 5 and 6)
epresent CMV epitope tags.1994, 1998; Maul et al., 1993; Leopardi et al., 1996; Roizman
and Furlong, 1974; Ward et al., 1996). We investigatedwhether UL20.5 protein is a component of either of two
previously described nuclear compartments that form at
late times postinfection. Capsid assembly occurs in nuclear
compartments that are distributed at the periphery of the
nucleus late in infection. This compartment is defined by
the presence of proteins associated with both immature
and mature capsids (Ward et al., 1996). The UL20.5 protein
did not colocalize with proteins associated with this com-
partment (data not shown). However, Fig. 9 shows that
UL20.5 did colocalize with components of a compartment
ssociated with late gene transcription. We previously re-
orted that at late times postinfection, the ICP22 protein
ocalizes to sites of transcription along with viral DNA, RNA
olymerase II, and ICP4 (Leopardi et al., 1996). Two late-
egulated viral proteins, UL4 (Jahedi et al., 1999) and UL3
Markovitz et al., 1999), were also recently found to localize
o this compartment. We investigated whether UL20.5 is
FIG. 5. Autoradiographic images of the electrophoretically separated
restriction digests of the DNAs of HSV-1(F), the parental virus R7214,
and the CMV-tagged recombinant virus, R7422. The DNAs were
cleaved with KpnI (lanes 1 and 2), EcoRV (lanes 3 and 4), and BamHI
(lanes 5–7, separated on a 1% agarose gel and transferred to a nitro-
cellulose sheet). The blot was probed with nick-translated pRB4324.
Positions of unique bands 1 and 2 indicative of the presence of CMV
tag 1 in R7422 and bands 3 and 4 indicative of the presence of CMV tag
2
Tare indicated. Positions of the HSV-1(F) KpnI H, EcoRV B, and BamHI
fragments are also indicated.
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279THE UL20.5 GENE OF HSV-1also distributed within this compartment by double-labeling
infected cells with mixtures of antibodies to CMV and either
ICP22, UL3, or UL4. Figures 9A and 9J show that in cells
infected with either HSV-1(F) or R7422 (carrying the CMV-
tagged UL20.5 ORF), ICP22 protein is distributed in discrete
spots primarily around the periphery of the nucleus. The
pattern of UL20.5 fluorescence almost completely overlaps
hat of ICP22 (Figs. 9). The UL3 and UL4 proteins are also
distributed in discrete spots around the nuclear periphery
(Figs. 9D and 9G); again, the fluorescence patterns of these
two proteins largely overlap that of UL20.5 (Fig. 9).
DISCUSSION
In the course of studies on the UL20 gene (Baines et
FIG. 6. Autoradiographic images of electrophoretically separated
estriction digests of the DNAs of a parental genotype virus and of the
MV-tagged recombinant virus R7427. The DNAs were cleaved with
pnI (lanes 1 and 2), separated on a 1% agarose gel, and transferred to
nitrocellulose sheet. The blot was probed with nick-translated
RB4324. Positions of unique bands indicative of the presence of the
pitope tag are indicated.l., 1991), we noticed that there was an unusually large
ntergenic sequence between the UL20 and UL21 ORFs.lthough this domain was not predicted to encode gene
roducts based on criteria listed by McGeoch et al.
1988), an examination of the nucleotide sequences both
ntisense to the UL20 gene and between the UL20 and
L21 genes showed the presence of at least four ORFs
with a coding capacity of more than 100 codons and one
ORF with a coding capacity of 86 codons. Three of these
ORFs that are antisense to UL20 were tagged with CMV
pitopes in the context of the viral genome, but no pro-
ein product reactive with the monoclonal antibody was
etected in lysates of cells infected with these recombi-
ant viruses (Fig. 7 and data not shown). This report
oncerns two of the ORFs. The ORF designated UL20.5
ies in its entirety between UL20 and UL21 in the same
rientation as UL20 ORF, whereas UL20.8 has the same
polarity as UL21 ORF. In this report, we show that the
L20.5 ORF is expressed, whereas we found no conclu-
sive evidence for the expression of UL20.8 ORF. The
ssues central to this report are an assessment of the
roperties of UL20.5 gene product and the significance of
ts discovery.
First, the nucleotide sequence of UL20.5 predicts a
FIG. 7. Immunoblot of mock-infected or virus-infected HEp-2 cell
lysates separated in a denaturing polyacrylamide gel, transferred to
nitrocellulose, and probed with the CMV antibody. Cells were infected
in the absence or presence of 300 mg/ml phosphonoacetic acid, an
inhibitor of viral DNA synthesis. Infected cells were harvested at 24 h
postinfection, and the cells were lysed, sonicated, and loaded onto an
SDS–polyacrylamide gel.
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280 WARD ET AL.protein of 160 amino acids. Because HSV proteins are
rich in proline and generally migrate in denaturing gels
more slowly than cellular proteins that serve as molec-
ular weight markers, the predicted size of the protein is
in good agreement with the apparent Mr of 24,000. Kyte-
Doolittle analysis of the amino acid sequence of UL20.5
protein shows that it is predominately hydrophilic (Fig.
10). Insertion of the CMV epitope into the DraIII site
placed the tag between amino acids 29 and 30, whereas
insertion of the epitope in the BstEII site placed the tag
between amino acids 100 and 101.
Second, the predicted amino acid sequence of UL20.5
ontains two consensus sites for N-linked glycosylation
t amino acids 49 and 92. Our studies do not address the
uestion of whether UL20.5 is modified by glycosylation.
lthough we have not seen the diffuse bands associated
ith glycosylated viral proteins, it is conceivable that the
nsertion of the tag precluded the glycosylation of the
rotein as was previously reported in the case of glyco-
rotein M (Baines and Roizman, 1993). It would be of
nterest to determine whether UL20.5 protein is glycosy-
ated inasmuch as relatively few nuclear proteins are
rocessed in this fashion. The production of polyclonal
ntiserum to this protein is under way.
Third, earlier studies designed to map RNA transcripts
FIG. 8. Immunoblot of R7422-infected HEp-2 cell nuclear and cyto-
plasmic extracts separated in a denaturing polyacrylamide gel. In-
fected cells were harvested at 20 h postinfection, and nuclear and
cytoplasmic fractions were separated as described under Materials
and Methods. The electrophoretically separated proteins were trans-
ferred nitrocellulose and reacted with the CMV antibody.n this region demonstrated the presence of at least five
ranscripts by hybridization of electrophoretically sepa- mated poly(A)1 RNA with labeled BamHI F9 or BamHI T
ragments of HSV-1 (Costa et al., 1981). An additional
inor transcript (3.1 kbp) was mapped antisense to the
L20.5 gene (Costa et al., 1984). Because there does not
appear to be a polyadenylation signal downstream of
UL20.5 or of UL20, the transcript for UL20.5 may be co-
erminal with UL19. There are no potential TATA box
equences upstream of UL20.5 until nucleotide 42395
(TAAT) or 42563 (TATA), with the exception of one A/T-rich
region approximately 150 bp upstream of the initiation
codon. The transcript for the UL20.5 gene, then, could be
s long as 7–7.4 kb, which is consistent with RNAs
reviously described for this region, although the precise
ranscripts for either UL20 or UL20.5 have not been iden-
ified.
Fourth, expression of the protein is completely abol-
shed by the treatment of infected cells with phosphono-
cetate, suggesting UL20.5 is regulated as a g2 gene and
that transcription of UL20.5 is separate from that of UL20
given that UL20 is regulated as a g1 gene (Ward et al.,
1994). In addition, UL20 protein is expressed at normal
levels in cells infected with the R7214 virus in which the
UL20.5 ORF is interrupted by the presence of the a27-tk
cassette within the UL20.5 coding sequence (data not
hown), further suggesting that the two proteins are
ncoded by separate transcription units.
Fifth, the CMV-tagged UL20.5 protein localizes in the
nucleus of infected cells. We should note that extensive
earlier studies involving the CMV epitope tag indicate
that although it may affect processing of the protein, it
does not impart on the tagged protein a specific local-
ization signal (Baines et al., 1991; Baines and Roizman,
993). Studies with the aid of confocal microscopy re-
ealed that UL20.5 protein colocalizes in small dense
uclear structures with ICP22, UL3, and UL4 proteins.
The results of earlier studies from our laboratory indi-
cated that ICP22 localizes in small dense nuclear struc-
tures and that with the onset of viral DNA synthesis these
structures contain nascent DNA, RNA polymerase II, the
major viral regulatory protein ICP4, and others. The ag-
gregation of these proteins in the small nuclear dense
structures was dependent on the presence of a func-
tional UL13 gene that encodes a protein kinase (Leopardi
t al., 1996). Recent studies indicate that late in infection,
his compartment accumulates UL3 and UL4 proteins
(Jahedi et al., 1999; Markovitz and Roizman, manuscript
in preparation). Accumulation of UL3 protein, at least, is
dependent on the presence of intact a22/US1.5 genes.
lthough earlier in infection the formation of the small
ense nuclear structures correlates with optimal expres-
ion of a subset of late genes whose expression is
ependent on a22/US1.5 genes, the function of the small
uclear dense structures late in infection is less well
nderstood.Sixth, the recombinant virus R7214 containing the chi-
eric a27-tk gene inserted within the coding sequence
icative
281THE UL20.5 GENE OF HSV-1of UL20.5 replicated normally in several cell lines (Baines
et al., 1991). These results indicate that the UL20.5 gene
is not required for viral replication in cultured cells tested
to date. The discovery of the UL20.5 gene adds to the
number of genes whose function is not required in cul-
tured cells. Furthermore, the phenotype of the R7214
FIG. 9. Digital images of R7422-infected Vero cells fixed at 16 h pos
the 20.5 ORF and ICP22 U23 or U24 proteins. Yellow fluorescence is ind
L).virus suggests that the previously described phenotypes
of UL20
2 and UL21
2 viruses reflect the absence of func-tions of the corresponding genes rather than that of
UL20.5 (Baines et al., 1991).
Seventh, a comparison of the genomic sequences of
HSV-1 (McGeoch et al., 1988) and HSV-2 (Dolan et al.,
1998) showed that there exists a region of homology
beginning at nucleotide 42021 in type II (corresponding
n and reacted with antibodies to the CMV epitope tag located within
of colocalization of the red and green fluorescent signals (C, F, I, andtinfectioto codon 47 of 20.5 in type I) and extending to nucleotide
41673 (corresponding to codon 150 of 20.5 in HSV-1).
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282 WARD ET AL.However, this region of homology is interrupted by two
stop codons and two frame shifts, and therefore we
conclude that the HSV-1 UL20.5 gene is not conserved in
he published sequence of HSV-2. We envision three
ossibilities: (1) HSV-1 and HSV-2 are not totally colinear,
nd because they have distanced themselves in the
ourse of evolution, there is no reason to expect that they
hould be; (2) the sequenced genome is that of a high
assage laboratory strain with at least one documented
ther mutation (Fenwick and Everett, 1990); and (3) the
omain thought to be intergenic contains errors. The
iscovery of the UL20.5 ORF underscores the conclusion
that even large viruses such as HSV-1 store genetic
information in a very compact fashion and do not carry
nucleotide sequences that provide neither instruction
nor information. In the case of HSV-1, several recently
described genes suggest that the density of encoded
information is high. There are several examples in which
two genes either overlap entirely in the same polarity
and sequence (UL26 and UL26.5, UL8.5 and UL9.5, a22
nd US1.5 and ORF P and ORF O), or are antisense to
ach other (g134.5 and ORF P, UL43 and UL43.5, and UL27
and UL27.5). Two genes, UL16 and UL17, are contained
within the intron of UL15. In recent years, there have been
several demonstrations that ORFs located between
known genes are expressed. For example, UL49.5 lies
etween UL49 and UL50, and US8.5 is contained largely
in a domain unoccupied by US8 and US9. We expect that
dditional, previously unrecognized genes remain to be
dentified.
MATERIALS AND METHODS
ells and viruses
HSV-1 strain F [HSV-1(F)] is the prototype HSV-1 strain
sed in our laboratories (Ejercito et al., 1968). Recombi-
ant viruses made for these studies were derived from
7214, a recombinant virus in which a chimeric gene
onsisting of the a27 promoter fused to the coding se-
uences of the tk gene (a27-tk) was inserted between
FIG. 10. Kyte-Doolittle plot generated with the translated DNA se-
uence of the UL20.5 ORF using a moving window of nine amino acids.
The sites of the CMV epitope insertions (F) and consensus sites for
N-linked glycosylation () are indicated.UL20 and UL21 (Baines et al., 1991). Viral stocks of HSV-
1(F) were made in HEp-2 cells, and stocks of recombi-nant viruses were made and titrated in Vero cells. Trans-
fections were performed in rabbit skin cells originally
obtained from J. McClaren. Selections of tk2 and tk1
viruses were done in 143TK2cells originally obtained
from Carlo Croce. The cell lines were maintained in
Dulbecco’s modified Eagle’s medium supplemented with
either 5% newborn calf serum (rabbit skin, Vero, or HEp-2
cells) or 5% fetal calf serum (143TK2 cells).
lasmids
Restriction endonucleases and T4 polymerase were
btained from New England Biolabs (Beverly, MA). T4
NA ligase was obtained from U.S. Biochemical (Cleve-
and, OH). The Klenow fragment of DNA polymerase was
btained from Boehringer-Mannheim Biochemicals (In-
ianapolis, IN).
pRB4324 contains a portion of the HSV-1(F) BamHI F9
nd T fragments in the form of a 1.9-kb PstI–SacI frag-
ent cloned into pGEM3Z (Ward et al., 1994). An 855-bp
gII–SacI fragment from pRB4324 was cloned into the
amHI and SacI sites of pGEM3Z and designated
RB465l. To tag the UL20.5 ORF (oriented right-left from
nucleotide 42016–41534 according to the sequence pub-
lished in McGeoch et al., 1988), pRB4651, which contains
the entire coding sequence of the UL20.5 gene and
ortions of the UL20 and UL21 genes, was digested with
stEII and the cohesive ends filled in with T4 polymer-
se. A blunt-ended double-stranded DNA oligomer con-
aining a KpnI restriction enzyme site (59 AAGGGACA-
AAGCCCAACCTGCTAGACCGACTGCGACACCGCAAA-
ACGGTACGCA CG 39) and its complement, encoding a
MV epitope (Baines et al., 1991), was ligated in the
same orientation as the UL20.5 ORF. This plasmid was
esignated pRB4795. To insert a second CMV tag into
he UL20.5 ORF, pRB4795 was cleaved with DraIII, and a
66-bp DNA oligomer (encoding the CMV epitope) with
DraIII cohesive ends and an EcoRV restriction site (CMV
tag 2: 59-GTAAAGGTCAAAAACCTAATTTGTTAGATAG-
GTTAAGGCATAGAAAGAATGGATATCG GCATCGCG-39)
and its complement 59-GATGCGGATATCCATTCTTCTAT-
GCCTTAACTAT CTAACAAATTAGGTTTTTGACCTTTAC-
CGC-39) was ligated in-frame with the UL20.5 ORF. The
esulting plasmid was designated pRB4858. The DNAs
ncoding the CMV epitopes and flanking sequences
ere sequenced to verify that the tags were intact and
n-frame. To tag the UL20.8 ORF, pRB4324 was digested
ith DraIII, the cohesive ends filled in with T4 polymer-
se, and the blunt-ended double-stranded DNA 60-bp
ligomer “CMV tag 1” containing a KpnI restriction site
as ligated in-frame with the UL20.8 ORF. The DNA
encoding the CMV epitopes and flanking sequences
were sequenced to verify that the tags were intact and
in-frame.
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283THE UL20.5 GENE OF HSV-1Selection of recombinant viruses
tk2 viruses progeny viruses were selected on 143TK2
cells in the presence of bromodeoxyuridine as previously
described (Post and Roizman, 1981). After two rounds of
selection under bromodeoxyuridine, plaques were
picked on Vero cells that were overlaid with medium 199
supplemented with 1% calf serum and 0.2% pooled hu-
man g-globulin.
urification and analysis of viral DNA
DNA intended for transfections was prepared from
otassium acetate gradients as previously described
Igarashi et al., 1993). All other DNA samples were puri-
ied by phenol–chloroform extraction of cytoplasmic ex-
racts of infected Vero cells (Tognon et al., 1983). Nick-
ranslations were done with the aid of a kit in accordance
ith the recommendations of the manufacturer (DuPont,
ilmington, DE). Separation of DNA fragments and
ransfer to nitrocellulose were done according to the
ethod of Southern (1975) as modified by Longnecker
nd Roizman (1986). Hybridization conditions were as
reviously described (Mocarski et al., 1980; Post et al.,
980).
reparation of template DNA and in vitro transcription
A 440-bp fragment encompassing ORFs 20.5 and 20.8
nucleotides 41597–42037) was amplified from pRB4324
ith PCR. The oligonucleotides used for the amplifica-
ion reaction carried EcoRI and BamHI restriction sites at
9 and 39 ends, respectively. The PCR fragment was
loned into the EcoRI and BamHI restriction sites of
GEM3Z. The orientation was such that the T7 polymer-
se transcribed UL20.8 and the SP6 promoter transcribes
UL20.5 (see Fig. 1 for arrangement of ORFs). To synthe-
ize labeled RNA probes, the MAXIscript in vitro tran-
cription kit (Ambion, Austin, TX) was used according to
he manufacturer’s protocol. Briefly, 1 ml of HindIII or
coRI-linearized plasmids was mixed with [a-32P]UTP
nd the T7 or SP6 polymerases and incubated for 1 h at
7°C. To remove the DNA template, 1 ml of DNase I was
added to the mixture, and the incubation was continued
for an additional 15 min. The full-length transcripts were
separated from prematurely terminated transcription
products as well as from unincorporated nucleotides by
gel purification.
RNA preparation and ribonuclease protection assay
HEp-2 and Vero cells grown in 150-cm2 flasks were
either mock-infected or exposed to 10 PFU of HSV-1(F)
virus/cell and harvested at 18 h after infection. Total RNA
was extracted with Trizol (GIBCO BRL) and digested with
amplification grade DNase (GIBCO BRL) according to the
manufacturer’s instructions. Then 10 mg of total RNA was
incubated overnight at 56°C with labeled RNA probe
g
m(1.5 3 105 cpm), complementary to the target RNA to be
etected. After hybridization, the mixture was treated
ith the appropriate amount of RNase A–RNase T1 mix
o degrade unhybridized probe. Labeled probe protected
y hybridization with cRNA was separated on 5% poly-
crylamide gels and detected by autoradiography.
ntibodies
The monoclonal antibody CH28–2 reacts with a 20-
mino-acid epitope derived from the human cytomega-
ovirus glycoprotein B gene (Liu and Roizman, 1991) and
as obtained from Goodwin Cancer Research Institute,
lantation Fl. A 1:500 dilution of the antibody was used in
mmunofluorescence assays and for immunoblots. Rab-
it polyclonal antibodies against the ICP22 protein was
enerated using a GST fusion construct containing the
ntire ICP22 coding sequence (Mitchell and Roizman,
npublished results). Rabbit polyclonal antibody against
he UL3 protein (Markovitz et al., 1999) was used at a
dilution of 1:1000. Rabbit polyclonal antisera to the UL4
rotein (Jahedi et al., 1999) was used at a dilution of
1:500. The goat anti-rabbit Texas red-conjugated anti-
body was obtained from Molecular Probes, Inc. (Eugene,
OR). The goat anti-mouse FITC-conjugated antibody was
obtained from Sigma (St. Louis, MO). The goat anti-
mouse alkaline phosphatase-conjugated antibody was
obtained from BioRad Laboratories (Richmond, CA).
Commercially obtained antibodies were used as recom-
mended by the manufacturer.
Polyacrylamide gel electrophoresis and
immunoblotting
Infected-cell lysates were separated in denaturing
gels consisting of 12.5% or 15% polyacrylamide
crosslinked with DATD and 0.1% SDS. Proteins were
electrically transferred to nitrocellulose blots, and the
blots were reacted with antibody and developed as pre-
viously described (Ward et al., 1994).
Immunofluorescence
Approximately 5 3 104 Vero cells were seeded onto
lass slides (Cell-line Inc., Nawfield, NJ) and allowed to
ttach overnight. Cells were infected with 10 PFU of
irus/cell and fixed in ice-cold methanol at 16 h postin-
ection. Slides were blocked in PBS containing 1% BSA
nd 20% human sera for 1 h at room temperature; re-
cted for 2 h at room temperature with a mixture of
ntibodies to CMV and either ICP22, UL3, or UL4 proteins
n PBS supplemented with 1% BSA and 10% human sera;
insed extensively with PBS; reacted for 1 h with a mix-
ure of anti-mouse secondary antibody conjugated to
ITC and anti-rabbit secondary antibody conjugated to
exas Red; rinsed extensively again; and mounted in 90%
lycerol in PBS containing 1 mg of p-phenylenediamine/
l. The slides were examined by confocal microscopy
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284 WARD ET AL.and digitized images of the fluorescent profiles were
acquired using software provided with the Zeiss confocal
microscope. The images were processed using Adobe
photoshop and printed by a Tektronix 440 phaser color
printer.
Cell fractionation
To prepare nuclear and cytoplasmic extracts, in-
fected 143TK2 cells were rinsed in PBS and resus-
pended in 1 mM phosphate buffer, pH 7.4, containing
0.25 M sucrose, and placed on wet ice for 15 min. The
plasma membrane was then lysed by the addition of
0.5% Nonidet P-40, the mixture was briefly vortexed,
maintained on wet ice for an additional 15 min, and
then centrifuged in a table top Beckman centrifuge to
separate the nuclei from the cytoplasm. The cytoplas-
mic extract was poured into a separate tube, and the
nuclear pellet was gently washed twice with 1 mM
phosphate buffer. Disruption buffer containing 2% SDS
and 0.5% b-mercaptoethanol was added to each frac-
ion before sonication and electrophoresis on dena-
uring polyacrylamide gels.
ACKNOWLEDGMENTS
This study was supported by Grants CA47451, CA71933, and
CA78766 from the National Cancer Institute and by the United States
Public Health Service.
REFERENCES
Baines, J. D., and Roizman, B. (1993). The UL10 gene of herpes simplex
virus 1 encodes a novel viral glycoprotein, gM, which is present in
the virion, and in the plasma membrane of infected cells. J. Virol. 67,
1441–1452.
aines, J. D., Ward, P. L., Campadelli-Fiume, G., and Roizman, B. (1991).
The UL20 gene of herpes simplex virus 1 encodes a function nec-
essary for viral egress. J. Virol. 65, 6414–6424.
Baradaran, K., Dabrowski, C. E., and Schaffer, P. A. (1994). Transcrip-
tional analysis of the region of the herpes simplex virus type 1
genome containing the UL8, UL9, and UL10 genes, and identification
of a novel delayed-early gene product, OBPC. J. Virol. 68, 4251–4261.
arker, D. E., and Roizman, B. (1992). The unique sequence of the
herpes simplex virus 1 L component contains an additional trans-
lated open reading frame designated UL49.5. J. Virol. 66, 562–566.
Carter, K. L., and Roizman, B. (1996). The promoter and transcriptional
unit of a novel herpes simplex virus 1 a gene is contained in, and
encodes a protein in frame with, the open reading frame of the a22
gene. J. Virol. 70, 172–178.
Chang, Y.-E., Menotti, L., Filatov, E., Campadelli-Fiume, G., and Roiz-
man, B. (1998). UL27.5 is a novel g2 gene antisense to the HSV-1 gene
encoding glycoprotein B. J. Virol. 72, 6056–6064.
hou, J., and Roizman, B. (1990). The herpes simplex virus 1 gene for
ICP34.5, which maps in inverted repeats, is conserved in several
limited-passage isolates but not in strain 17syn1. J. Virol. 64, 1147–
1156.
osta, R. H., Cohen, G., Eisenberg, R., Long, D., and Wagner, E. (1984).
Direct demonstration that the abundant 6-kilobase herpes simplex
virus type 1 mRNA mapping between 0.23, and 0.27 map units
encodes the major capsid protein VP5. J. Virol. 49, 287–292.osta, R. H., Gayathri Devi, B., Anderson, K. P., Gaylord, B. H., and
Wagner, E. K. (1981). Characterization of a major late herpes simplex
virus type 1 mRNA. J. Virol. 38, 483–496.
e Bruyn Kops, A., and Knipe, D. M. (1994). Preexisting nuclear archi-
tecture defines the intranuclear location of herpesvirus DNA repli-
cation structures. J. Virol. 68, 3512–3526.
e Bruyn Kops, A., and Knipe, D. M. (1988). Formation of DNA replica-
tion structure in herpes simplex virus requires a viral DNA binding
protein. Cell 55, 857–868.
olan, A., Jamieson, F. E., Cunningham, C., Barnett, B. C., and Mc-
Geoch, D. (1998). The genome of herpes simplex virus type 2. 72,
2010–2021.
jercito, P. M., Kieff, E. D., and Roizman, B. (1968). Characterization of
herpes simplex virus strains differing in their effects on social be-
havior of infected cells. J. Gen. Virol. 2, 357–364.
enwick, M. L., and Everett, R. D. (1990). Transfer of UL41, the gene
controlling virion-associated host shutoff, between two strains of
herpes simplex virus. J. Gen. Virol. 71, 411–418.
Georgopoulou, U., Michaelidou, A., Roizman, B., and Mavromara-Na-
zos, P. (1993). Identification of a new transcriptional unit that yields a
gene product within the unique sequence of the short component of
the herpes simplex virus 1 genome. J. Virol. 67, 3961–3968.
Igarashi, K., Roller, R., and Roizman, B. (1993). Construction, and prop-
erties of a recombinant herpes simplex virus 1 lacking both S-
component origins of DNA synthesis. J. Virol. 67, 2123–2132.
ahedi, S., Markovitz, N. S., Filatov, F., and Roizman, B. (1999). Colocal-
ization of the herpes simplex virus 1 UL4 protein with infected cell
protein 22 in small, dense nuclear structures formed prior to onset of
DNA synthesis. J. Virol. 73, 5132–5136.
ohnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M., and N. D. Stow,
N. D. (1988). Herpes simplex virus immunoglobulin G Fc receptor
activity depends on a complex of two viral glycoproteins, gE, and gI.
J. Virol. 62, 1347–1354.
agunoff, M., and Roizman, B. (1994). Expression of a herpes simplex
virus 1 open reading frame antisense to the g1 34.5 gene and
transcribed by an RNA 39 coterminal with the unspliced latency-
associated transcript. J. Virol. 68, 6021–6028.
eopardi, R., Ward, P. L., Ogle, W. O., and Roizman, B. (1996). Associa-
tion of herpes simplex virus regulatory protein ICP22 with transcrip-
tional complexes containing EAP, ICP4, RNA polymerase II and viral
DNA requires posttranslational modification by the UL13 protein
kinase. J. Virol. 71, 1133–1139.
iu, F., and Roizman, B. (1991). The promoter, transcriptional unit, and
coding sequences of herpes simplex virus 1 family 35 proteins are
contained within, and in frame with the UL26 open reading frame.
J. Virol. 65, 206–212.
ongnecker, R., and Roizman, B. (1986). Generation of an inverting
herpes simplex virus 1 mutant lacking the L-S junction a sequences,
an origin of DNA synthesis, and several genes including those
specifying glycoprotein E, and the a´47 gene. J. Virol. 58, 583–591.
arkovitz, N. S., Filatov, F., and Roizman, B. (2000).The UL3 protein of
herpes simplex virus 1 is translated predominantly from the second
in-frame methionine codon, and is subject to at least two post-
translational modifications. J. Virol. 74, 523–528.
aul, G. G., Guldner, H. H., and Spivak, J. G. (1993). Modification of
discrete nuclear domains induced by herpes simplex virus type 1
immediate early gene 1 product (ICPO). J. Gen. Virol. 74, 2679–2690.
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C.,
McNab, D., Perry, L. J., Scott, J. E., and Taylor, P. (1988). The complete
DNA sequence of the long unique region in the genome of herpes
simplex virus type 1. J. Gen. Virol. 69, 1531–1574.
Mocarski, E. S., Post, L. E., and Roizman, B. (1980). Molecular engineer-
ing of the herpes simplex virus genome: Insertion of a second L-S
junction into the genome causes additional genome inversions. Cell
22, 243–255.
Post, L. E., Conley, A. J., Mocarski, E. S., and Roizman, B. (1980). Cloning
W285THE UL20.5 GENE OF HSV-1of reiterated and nonreiterated herpes simplex virus 1 sequences as
BamHI fragments. Proc. Natl. Acad. Sci. USA 77, 4201–4205.
Post, L. E., and Roizman, B. (1981). A generalized technique for deletion
of specific genes in large genomes: a gene 22 of herpes simplex
virus 1 is not essential for growth. Cell 25, 227–232.
Randall, G., Lagunoff, M., and Roizman, B. (1997). The product of ORF O
located within the domain of herpes simplex virus 1 genome tran-
scribed during latent infection binds to and inhibits in vitro binding of
infected cell protein 4 to its cognate DNA site. Proc. Natl. Acad. Sci.
USA 94, 10379–10384.
Roizman, B., and Furlong, D. (1974). The replication of herpesviruses, In
“Comprehensive Virology,” Vol. 3 (H. Fraenkel-Conrat and R. R. Wag-
ner, Eds.), pp. 229–403, Plenum Press, New York.
Sheldric, P., and Berthelot, B. (1975). Inverted repetitions in the chro-
mosome of herpes simplex virus. Cold Spring Harbor Symp. Quant.
Biol. 39, 667–678.Southern, E. M. (1975). Detection of specific sequences among DNA
fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503–517.
Tognon, M., Cassai, E., Rotola, A., and Roizman, B. (1983). The heter-
ogenous regions in herpes simplex virus 1 DNA. Microbiologica 6,
191–198.
Wadsworth, S., Jacob, R. J., and Roizman, B. (1975). Anatomy of herpes
simplex virus DNA. II. Size, composition, and arrangement of inverted
terminal repetitions. J. Virol. 15, 1487–1497.
Ward, P. L., Barker, D. E., and Roizman, B. (1996). A novel herpes
simplex virus 1 gene, UL43.5, maps antisense to the UL43 gene and
encodes a protein which colocalizes in nuclear structures with cap-
sid proteins. J. Virol. 70, 2684–2690.
ard, P. L., Campadelli-Fiume, G., Avitabile, E., and Roizman, B. (1994).
Localization, and putative function of the UL20 membrane protein in
cells infected with herpes simplex virus 1. J. Virol. 68, 7406–7417.
